MedBright AI Announces the Appointment of Christopher Heath as CEO and Termination of Letter of Intent
VANCOUVER, British Columbia, Aug. 09, 2024 (GLOBE NEWSWIRE) — MedBright AI Investments Inc. (the “Company” or “MedBright AI“) (CSE:MBAI, OTCQB:MBAIF, […]